Abstract | BACKGROUND: It has remained unclear whether genetic background of patients with atopic eczema (AE) alone is identical to that of patients with both AE and atopic respiratory disease. OBJECTIVE: We aimed to assess whether there is a genetic difference between these two groups of AE patients. METHOD: We determined the genotype with regard to an allelic polymorphism in the gene for mast cell chymase (MCC; a serine protease secreted from mast cells) in 169 AE patients. RESULTS: MCC genotype was significantly associated with pure AE patients who did not have a predisposition to atopic respiratory disease and whose serum IgE concentration was < 500 IU/mL. The distribution of MCC genotypes also differed significantly between the latter patients and those AE patients with bronchial asthma and a serum IgE concentration of > 2000 IU/mL. CONCLUSION: These results suggest that pure AE is associated with genetic variants of MCC, and that the genetic basis of pure AE differs from that of AE associated with atopic asthma.
|
Authors | K Tanaka, H Sugiura, M Uehara, H Sato, T Hashimoto-Tamaoki, J Furuyama |
Journal | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
(Clin Exp Allergy)
Vol. 29
Issue 6
Pg. 800-3
(Jun 1999)
ISSN: 0954-7894 [Print] England |
PMID | 10336597
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Immunoglobulin E
- Serine Endopeptidases
- Chymases
|
Topics |
- Adolescent
- Adult
- Asthma
(complications, genetics)
- Child
- Chymases
- Eczema
(complications, genetics)
- Female
- Genotype
- Humans
- Hypersensitivity
(blood, complications, genetics)
- Immunoglobulin E
(blood)
- Male
- Mast Cells
(enzymology)
- Rhinitis, Allergic, Seasonal
(complications, genetics)
- Serine Endopeptidases
(genetics)
|